Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

683 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Guest editor's bio.
Lanza F. Lanza F. Transfus Apher Sci. 2023 Dec;62(6):103842. doi: 10.1016/j.transci.2023.103842. Epub 2023 Oct 31. Transfus Apher Sci. 2023. PMID: 37923674 No abstract available.
Novel insights and therapeutic approaches in secondary AML.
Marconi G, Rondoni M, Zannetti BA, Zacheo I, Nappi D, Mattei A, Rocchi S, Lanza F. Marconi G, et al. Among authors: lanza f. Front Oncol. 2024 Jul 29;14:1400461. doi: 10.3389/fonc.2024.1400461. eCollection 2024. Front Oncol. 2024. PMID: 39135995 Free PMC article. Review.
[No title available]
[No authors listed] [No authors listed] PMID: 39137718
A report from the SIdEM: Italy.
Ostuni A, Accorsi P, Mazzoni A, Vacca M, Colpo A, Agostini V, Crovetti G, Iuliani O, Michelotti A, Rondinelli MB, Zanella A, Antozzi C, De Silvestro G, Lanza F, Montanari M, Trinchero M; SIdEM Corporate Offices. Ostuni A, et al. Among authors: lanza f. Transfus Apher Sci. 2023 Aug;62(4):103761. doi: 10.1016/j.transci.2023.103761. Epub 2023 Jul 15. Transfus Apher Sci. 2023. PMID: 37495449 No abstract available.
[No title available]
[No authors listed] [No authors listed] PMID: 38692164
Impact of Pre-Treatment Comorbidity Burden on Survival in Patients Receiving Venetoclax Plus Hypomethylating Agents.
Marconi G, Petracci E, Lanzarone G, Vetro C, Martelli MP, Papayannidis C, Audisio E, Minetto P, Riva C, Guolo F, Martini G, Zappasodi P, Vincenzo F, Gigli F, Griguolo D, Rondoni M, Ciotti G, Borlenghi E, Ciccone N, Palumbo FE, Nanni J, Mattei D, Bernardi M, Cignetti A, Zingaretti C, Vertogen B, Cerchione C, Lanza F, Cilloni D, Brunetti L, Palmieri R, Curti A, Giannini MB, Todisco E; AVALON research group; Fracchiolla N, Martinelli G. Marconi G, et al. Among authors: lanza f. Am J Hematol. 2025 Jan 20. doi: 10.1002/ajh.27591. Online ahead of print. Am J Hematol. 2025. PMID: 39831709
683 results